Moderna gave investors a scare as its stock plunged on Thursday. But it’s still one of the hottest biotechs this year. And it’s hardly alone – the sector is on a roll and looks poised for more gains. The iShares Biotechnology ETF (IBB) is up 24% through October 23, building on a 28% gain in 2025. Two dozen of the ETF’s 233 holdings have more than doubled year-to-date. Moderna leads the pack with a 587% surge — even after an […]
Source
According to CNBC, the ETF iShares Biotechnology rises 24% in the year and 24 of its 233 shares have already doubled in value with the new innovation cycle